Medicines for human purposes for the treatment of schizophrenia in adults; medicines for human purposes for the treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; chemical preparations for pharmaceutical purposes, namely, for the treatment of schizophrenia in adults; chemical preparations for pharmaceutical purposes, namely, for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabi...